Show simple item record

dc.contributor.authorWang, Xu
dc.contributor.authorCabrera Castillo, María Teresa 
dc.contributor.authorLópez Nevot, Miguel Ángel 
dc.date.accessioned2021-03-10T12:01:17Z
dc.date.available2021-03-10T12:01:17Z
dc.date.issued2021
dc.identifier.citationXu Wang, Yoel Genaro Montoyo-Pujol, Sandra Bermudez, Gonzalo Corpas, Aurelio Martin, Francisco Almazan, Teresa Cabrera, Miguel Angel López-Nevot, "Serum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasis", Journal of Oncology, vol. 2021, Article ID 6610769, 9 pages, 2021. https://doi.org/10.1155/2021/6610769es_ES
dc.identifier.urihttp://hdl.handle.net/10481/67057
dc.description.abstractPurpose. Previous studies have shown that melanoma cells produce excessive levels of cytokines, which have various biological roles during melanoma development. The aim of this study was to expand the profile of serum cytokines, chemokines, growth factors, and angiogenic factors that are associated with melanoma, to find more cytokines with abnormal concentrations in melanoma patients, to identify whether the level of cytokines correlated with prognostic variants, such as Breslow thickness and BRAF mutation, and, finally, to find out the cytokines that play important roles during melanoma development. Materials and Methods. Multiplex immunobead assay technology and 45-plex immunoassays ProcartaPlex (TM) kits were used to simultaneously compare the levels of cytokines, growth factors, angiogenic factors, and chemokines between the serum of healthy patients (n = 30) and those with melanoma (n = 72). Data were analyzed according to the clinical characteristics of the designated patient subgroups. Results. Compared to the control group, melanoma patients had higher levels of VEGF-A, PDGF-BB, IL-1RA, PIGF-1, IFN-gamma, TNF-alpha, MIP-1 alpha, and SCF, but lower levels of BDNF, SDF-1 alpha, MCP-1, Eotaxin, EGF, and IL-7. Furthermore, the levels of TNF-alpha (P=0.320, r = 0.019), IFN-gamma (P=0.311, r = 0.023), VEGF-A (P=0.014, r = 0.337), and BDNF (0.004, r = -0.391) showed a significant correlation with Breslow thickness. IL-7 was of lower levels in patients harboring BRAF mutants. Melanoma patients with high levels of MIP-1 alpha and MCP-1 showed the poorest overall survival. Conclusions. We found that the levels of VEGF-A and PDGF-BB in the serum of both primary and metastatic melanoma patients are elevated. TNF-alpha, IFN-gamma, and VEGF-A presented a positive correlation with Breslow thickness, whereas BDNF showed a negative association. MIP-1 alpha and MCP-1 correlated negatively with survival. In addition, lower levels of IL-7 were found in patients harboring BRAF mutants. These findings indicate that these cytokines may play critical roles in the progression of melanoma.es_ES
dc.description.sponsorshipInstituto de Salud Carlos II FISS PI 13/02119es_ES
dc.language.isoenges_ES
dc.publisherHINDAWI LTDes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleSerum Cytokine Profiles of Melanoma Patients and Their Association with Tumor Progression and Metastasises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1155/2021/6610769


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España